{"bbsInfo":{"REG_DT":"2026-06-19 10:49:34","MENU_SEQ":57,"BBS_LANG":"E","VIEW_DT":"2026.04.23 00:00:00","BBS_TITLE":"Ildong Pharmaceutical Hosts Beauty Class for PDRN Functional Cosmetic ‘REJUNIQ’","BBS_SEQ":4230,"BBS_CONTENTS":"

Ildong Pharmaceutical Hosts Beauty Class for PDRN Functional Cosmetic ‘REJUNIQ’
\r\nInfluencers from Diverse Fields Gather to Share Experiences and Product Ideas

\r\n\r\n

Ildong Pharmaceutical (Co-CEOs: Paul Woongsup Yun and Chae Joon Lee) held a “REJUNIQ Beauty Class” event featuring its PDRN-based functional cosmetic product, REJUNIQ PDRN Rejuvenating & Repair Cream (hereinafter referred to as “REJUNIQ”).

\r\n\r\n

The event took place on April 22 at the company’s headquarters in Seocho-gu, Seoul, and was attended by approximately 20 influencers from a wide range of professions, including models, announcers, professional golfers, and marketing specialists.

\r\n\r\n

According to the company, the event provided an opportunity for participants to personally experience REJUNIQ while sharing skincare tips, lifestyle-based product usage ideas, and beauty know-how.

\r\n\r\n

As a pharmacy-exclusive cosmetic brand that reflects the identity and philosophy of a pharmaceutical company, the event went beyond a simple product trial. Instead, it focused on allowing participants to experience and connect with the product quality and brand value of REJUNIQ.

\r\n\r\n

REJUNIQ is a newly launched functional skincare product from Ildong Pharmaceutical designed to make the increasingly popular skincare ingredient PDRN (Poly Deoxy Ribo Nucleotide) readily accessible through local pharmacies.

\r\n\r\n

The product contains 15,000 ppm of Sodium DNA, a PDRN ingredient derived from Alaskan salmon, along with a variety of skin-enhancing ingredients, including:

\r\n\r\n\r\n\r\n

In addition, the formula includes:

\r\n\r\n\r\n\r\n

As part of the event, Ildong Pharmaceutical also conducted a pre-launch testing program using samples from upcoming products in the REJUNIQ Series. The company plans to utilize consumer feedback gathered during the testing process—including opinions on products currently in development—to further enhance product quality and refine its marketing strategies.

\r\n\r\n

Kim Seok Tae, Head of the OTC Division at Ildong Pharmaceutical, stated, “REJUNIQ was developed with a sufficiently high concentration of PDRN, taking into account both user benefits and accessibility, and has been launched as a functional cosmetic product distributed through pharmacies. Through continuous communication with consumers and diverse marketing campaigns, we aim to establish REJUNIQ as a brand that delivers a differentiated customer experience.”

\r\n","MENU_NM":"NEWS","VIEW_CNT":239,"REG_USER":"hp226121"},"searchData":{"bbsSeq":"4230","menuSeq":"57"}}